With the advent of effective antituberculous chemotherapy, the frequency.of central nervous system (CNS) tuberculosis has decreased in the developed countries. In Britain, however, CNS tuberculosis has again become a problem in areas with large immigrant communities. In a recent series from The London Hospital, 22 (81 %) of 27 patients with CNS tuberculosis were foreign-born (Traub et al. 1984) . Although the incidence of CNS tuberculosis has also declined in some less developed countries, for example in India (Lalitha et al. 1980 , Lalitha & Dastur 1980 , the'disease is still a serious medical problem worldwide. The difference in incidence of CNS tuberculosis between developed and developing countries probably reflects a combination of factors, especially the socioeconomic environment, nutritional state and immune status of the populations of these countries.
In Britain, CNS tuberculosis used to be primarily an illness of childhood and adolescence. Since 1970, of 46 reported cases of CNS tuberculoma, only 13 (29%) were under the age of 20 years (Maurice-Williams 1972 , Banna et al. 1973 , Thrush & Barwick 1974 , Anderson & Macmillan 1975 , Lindsay & Scholtz 1978 , Peatfield & Shawdon 1979 , Loizou & Anderson 1982 , Traub et al. 1984 . In 1983, 13 (30%) of 43 patients with tuberculous meningitis were younger than 20 years (Bateman et al. 1983 ). This declining incidence in children reflects the low incidence of pulmonary tuberculosis in the United Kingdom; the adult cases probably result from reactivation of dormant tuberculosis. On the other hand, CNS tuberculosis is still prevalent in children in India, where pulmonary tuberculosis occurs commonly in children.
Tuberculous meningitis (TBM)
TBM is a life-threatening condition. Inflammation of the meninges occurs in response to the release of Mycobacterium tuberculosis into the cerebrospinal fluid (CSF), probably almost invariably originating from a Rich's focus in the brain and meninges. TBM typically presents with a subacute course; the major features are fever, headache, neck stiffness and disturbance of consciousness. The illness is often difficult to recognize in its early stages and the tempo of development of the full clinical syndrome varies from a few days to several weeks.
Occasionally, it may present as a ess without signs of meningeal irritation.
Various neurological complications are associated with TBM, including cerebral oedema, hydrocephalus, cranial nerve palsies, hemiparesis, the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), grand mal seizures, spinal arachnoiditis and involuntary movements. Appropriate management of these complications is important in determining the outcome. Relief of hydrocephalus with ventriculoperitoneal CSF shunting, control of seizures with anticonvulsants and resolution of SIADH with correction of hyponatraemia may lead to immediate clinical improvement. Steroids should be used only if there is clinical. and radiological evidence of cerebral oedema.
Although the tuberculin skin test has been the traditional method of diagnosing tuberculous infection, it may be misleading. A negative skin test is not a reliable finding in the exclusion of the diagnosis of TBM and, conversely, a positive test is not diagnostic. Technical error in administration of the test, misinterpretation of the result, the immune status of the test subject, and the degree of specificity of the test material are all factors that may contribute to false positive or negative results. However, the tuberculin skin test may be a useful reminder of the diagnosis of TBM in a subacutely ill patient if it is interpreted in conjunction with other clinical features. Although the chest X-ray may be helpful in suggesting the presence of tuberculosis, it is normal in about 40% of cases with TBM (Kennedy & Fallon 1979 , Haas et al. 1977 .
CSF examination is essential in the diagnosis of TBM. The characteristic cytological and biochemical findings are well known, but these are often not present in the early stages of the disease. The role of CSF chloride levels in diagnosis is controversial. A low CSF chloride level may simply indicate hypochloraemia related to prolonged vomiting or SIADH in TBM. Although it has been shown that the CSF chloride level varies too much to be of diagnostic or prognostic significance (Lincoln & Kirmse 1950) , this test is still popular in some countries (D'Oliveira 1972 , Jaffe 1982 , Sandyk & Seftel 1983 , Schoen 1984 . Reduction of the CSF glucose level in relation to a simultaneous blood glucose level, with CSF lymphocytosis and a raised CSF protein level, strongly supports a clinical suspicion of TBM. However, the most important finding in the CSF is the demonstration of M. tuberculosis, either by acid-fast staining of the sedi-ment, or by culture. Unfortunately culture of the organism is slow to produce results and bacteriological proof of the diagnosis may be achieved in as few as 14% or as many as 90% of cases in different series of cases. Examination of repeated specimens has been recommended (Fallon & Kennedy 1982) , but this is often impractical for the clinician confronted by a sick patient in need of treatment. Whether the development of monoclonal antibody-based tests will prove of practical value in improving the specificity of immunological tests for CNS tuberculosis remains to be determined.
The CT brain scan is now a routine investigation in patients with suspected TBM. The positive findings include hydrocephalus, periventricular lucencies, basal enhancement, oedema, infarct and exudate over the convexities of the brain. Whether the presence of basal enhancement indicates a poor prognosis is controversial. In one series from India (Bhargava et al. 1982) , the presence of enhancing basal exudate implied a poor outcome, but 6 of 9 patients with -basal enhancement in a series from South Africa (Bullock & Welchman 1982) showed clinical improvement with treatment. The value of sequential CT scans in monitoring the response to therapy in TBM has been emphasized by Stevens & Everett (1978) .
Steroids have been used in TBM because of the theoretical advantages of their anti-inflammatory and antioedematous effects. However, there appears no convincing evidence in favour of their use. There is experimental evidence that steroids restore the vascular tone and circulation during inflammation (Ebert 1952) , but Sheld & Brodeur (1981) showed in animal experiments that steroids reduce CSF ampicillin levels. It is generally accepted that the routine use of steroids is not justified, since the risks of this treatment may outweigh these theoretical advantages. Only in the presence of clinically relevant cerebral oedema is their use justified.
The therapeutic dosages and preferred routes of administration of the commonly used antituberculous drugs are well established. Recently, however, a high dosage of isoniazid administered orally (Sandyk & Seftel 1983 ) and intraventricular administration of rifampicin (Dajez et al. 1981) have been tried in order to increase the concentrations of these drugs in the CSF. The use of intrathecal streptomycin is even more controversial. Although there is evidence that drugs given by the intrathecal route fail to enter the ventricular system (Koster et al. 1938 , Rieselbach et al. 1962 , Kaiser & McGee 1975 ), many clinicians (Stevenson 1973 , Parsons 1982 favour the intrathecal use of this drug in difficult cases. Assays of antituberculous drug levels in blood and CSF are not routinely available and there is no information on therapeutic CSF levels for most of the commonly used drugs. More information might well clarify the preferred dosages and routes of administration during the acute and convalescent stages of TBM.
CNS tuberculoma
In Britain the incidence of CNS tuberculoma in relation to diagnosed intracranial tumours was 34% in 1933 (Garland & Armitage 1933) , but only 2% in 1972 (Maurice-Williams 1972). However, the incidence of tuberculomas remains high in certain less-developed countries in which CNS tuberculosis is prevalent. In India, tuberculomas constitute 17% of intracranial mass lesions (Dastur & Dave 1977) ; in Nigeria 12.5% (Odeku & Adeloye 1969); and in Rhodesia (Zimbabwe) 14% (Levy 1973) . It is interesting to note, however, that in Taiwan, where CNS tuberculosis is still common (Tang et al. 1983 ), tuberculomas account for only 1% of intracranial mass lesions (Shih 1977) . This may, perhaps, indicate the importance of constitutional factors in the development of a cerebral mass lesion in response to the invasion of M. tuberculosis.
Intracranial tuberculomas may occur anywhere in the brain. Most tuberculomas are confined to the substance of the cerebrum and cerebellum, having a tendency to involve infratentorial regions in children and supratentorial structures in adults. Tuberculoma may present as an extracerebral lesion with a dural attachment, i.e. tuberculoma en plaque. Intracranial tuberculoma is said usually to be solitary, but 15-50% are multiple (Garland & Armitage 1933 , Asenjo et al. 1951 , Arseni 1958 The clinical symptomatology of intracranial tuberculoma is not specific. The symptoms and signs are mainly related to the mass effect of the lesion, together with its surrounding oedema, upon the site involved. Raised intracranial pressure and papilloedema are commonly encountered. However, less than half affected patients show signs of localization, and fever is not a feature.
About half of all patients with intracranial tuberculomas have evidence of active extracranial tuberculosis (Anderson & Macmillan 1975 , Mayers et al. 1978 . However, skin testing with purified protein derivative is positive in only 25% (Arseni 1958) , and the chest X-ray is abnormal in only. 30% (Mayers et al. 1978) .
Patients with intracranial tuberculomas frequently do not show the characteristic findings of tuberculous infection of the meninges, e.g. decreased sugar level, raised protein level and lymphocytosis. Indeed, the CSF profile may be completely normal, even in repeated specimens (Witham et al. 1979 ). Lumbar puncture is therefore not useful in investigation. Not only is there a risk of brain herniation but the yield of diagnostic information is low. Calcification is infrequently found in skull X-rays, occurring in only 6% (Ramamurthi & Varadarajan 1961) or less of cases (Asenjo et al. 1951 , Dastur & Desai 1965 ). Cerebral angiography usually shows an avascular spaceoccupying lesion. Although a superficial tuberculoma with a wide dural attachment may be associated with prominent middle meningeal vessels, there is no tumour circulation. Occasionally a sudden narrowing of the blood vessels traversing or adjacent to the lesion, thought to be due to tuberculous vasculitis, may be observed (Dastur & Desai 1965) .
The CT scan is superior to the isotope brain scan and to angiography in showing not only the location and diagnostic features of tuberculoma, but also in detecting oedema and herniation of the brain. This test is also reliable in demonstrating multiple lesions. It can be valuable, in serial studies, in monitoring medical therapy. Tuberculomas may improve within 3 months of beginning chemotherapy (Peatfield & Shawdon 1979 , Witham et al. 1979 , Lees et al. 1980 , Whelan & Stern 1981 , Tyler et al. 1983 ) although it took 6 months to show improvement in a case reported by Grabman & Kompare (1980) . The CT scan appearance of tuberculoma depends on the maturity of the lesion. In the early stages, when there is little encapsulation of the tuberculoma, the lesion tends to be of low density or isodense with nodular enhancement of contrast. In the later stages, when the capsule is well formed, the lesion appears to be isodense or minimally hyperdense with ring enhancement (Whelan & Stern 1981 , Price & Danzinger 1978 .
Before the era of antituberculous chemotherapy, surgical removal of tuberculoma was sometimes attempted. However, this was often followed by severe tuberculous meningitis, which frequently proved fatal. Later, surgical treatment was limited to decompression for the management of raised intracranial pressure. In Arseni's (1958) series, mortality from surgical resection and subsequent meningitis was 85%, while that from decompression alone was only 34%. In the era of modern chemotherapy, surgical extirpation of tuberculoma need no longer be associated with a high mortality. Thus the role of surgery has become controversial because of the success of medical treatment. There have been no prospective controlled trials comparing medical and surgical treatment in this condition, but Harder et al. (1983) found that conservative medical management was superior in terms of functional recovery. This approach has also been discussed by Traub et al. (1984) . Surgical treatment should therefore probably be reserved for patients in whom medical treatment has failed, or in whom there is a severe compressive or mass effect on the brain. Appropriately timed relief of obstructive hydrocephalus can be lifesaving, and often has a strikingly beneficial effect on the patient's clinical condition. This complication may also develop in the late stages of convalescence, leading to failure to make clinical progress, drowsiness or headache.
Cerebral oedema may be disproportionate in patients with tuberculoma, aggravating the mass effect and causing a poor clinical condition by displacement of intracranial structures. Steroids are recommended by most clinicians in the treatment of tuberculoma in order to reduce surrounding oedema, when it is present. Glycerol, a potent osmotic treatment for cerebral oedema, can be a useful alternative drug.
In many patients anticonvulsant drugs will be indicated, but these should not be used unless there is a clinical indication since seizures do not always complicate tuberculomas in the brain.
Antituberculous chemotherapy in CNS tuberculosis
There is no general agreement on which combination of drugs is most appropriate for CNS tuberculosis, although triple therapy is usually prescribed. Of the more than ten antituberculous drugs available, only fourrifampicin, isoniazid, pyrazinamide and streptomycinare bactericidal. The former three drugs, but not streptomycin, penetrate both an inflamed and a non-inflamed blood/brain barrier adequately. These bactericidal drugs are able to kill the rapidly multiplying tubercle bacilli and to prevent the occurrence of mutant strains. Thus, we recommend a three-drug combination of rifampicin, isoniazid and pyrazinamide for the initial 2 months of treatment. Thereafter, rifampicin and isoniazid should be continued for a long period, as long as a year or more, to eliminate slowly multiplying organisms. The role of streptomycin, the traditional mainstay of therapy, needs reappraisal when used in combination with these three drugs. It remains unknown for how long antituberculous chemotherapy should be continued in the treatment of CNS tuberculosis. Whether the duration of treatment can be shortened to a period of 9 months, as in the treatment of pulmonary tuberculosis, remains to be elucidated.
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